News

Kairos Pharma's Upcoming Engagement at the Maxim Healthcare Summit

Kairos Pharma's Upcoming Engagement at the Maxim Healthcare Summit

Engaging Insights from Kairos Pharma at Maxim Healthcare Summit

LOS ANGELES – Kairos Pharma Ltd. (NYSE American: KAPA), a prominent clinical-stage biopharmaceutical company, is excited to announce an engaging opportunity at the upcoming Maxim Healthcare Virtual Summit. This virtual event is set to provide crucial insights into the latest developments in the healthcare sector, and Kairos is positioned to be at the forefront of these discussions. John S. Yu, M.D., the company's Chief Executive Officer, will be featured in a fireside chat, covering essential topics related to oncology and its therapeutic advancements.

Fireside Chat Details

John S. Yu is scheduled to converse with Jason McCarthy, Ph.D., Senior Managing Director and Head of Biotechnology Research at Maxim Group. This chat will take place on October 17, 2024, at 1:00 PM ET, making it a highlight of the summit. Attendees will gain invaluable knowledge about the evolving landscape of biopharmaceuticals and how Kairos Pharma plays a pivotal role in innovation.

About the 2024 Maxim Healthcare Virtual Summit

The Maxim Healthcare Virtual Summit brings together leading experts, innovators, and stakeholders in the healthcare industry to share insights and drive forward-thinking discussions about the future of medical treatments and technologies. This platform is particularly crucial for understanding how companies like Kairos Pharma are addressing significant challenges in cancer treatment.

Kairos Pharma’s Mission in Oncology

Kairos Pharma Ltd. is committed to combating cancer through innovative treatment approaches. The company focuses on using structural biology to tackle common issues such as drug resistance and immune suppression encountered in cancer therapies. Their flagship product, ENV105, specifically targets CD105, a molecule associated with cancer treatment resistance. By inhibiting CD105, ENV105 aims to enhance the effectiveness of existing standard therapies, potentially providing new hope for patients battling various cancer types.

Clinical Advancements and Future Directions

Currently, ENV105 is undergoing crucial Phase 2 clinical trials for prostate cancer and Phase 1 trials for lung cancer. These trials are significant as they address unmet medical needs and aim to shift the paradigms of cancer treatment. The progress of these studies will play a substantial role in shaping the future of oncology therapeutics, and the insights shared at the Maxim Summit will highlight Kairos Pharma’s contributions and strategies.

Engagement with Investors and the Public

Kairos Pharma is dedicated to maintaining transparency and open communication with stakeholders. The participation in the Maxim Healthcare Virtual Summit not only serves to inform the healthcare community about their advancements but also fosters engagement with investors who are keenly interested in the company’s potential and future directions.

Looking Ahead: Opportunities for Growth

As the biopharmaceutical landscape continues to evolve, Kairos Pharma’s strategic initiatives aim to address the pressing health challenges faced globally. By focusing on innovative solutions and fostering collaborations within the healthcare sector, the company strives to enhance its impact on patient outcomes and further solidify its position as a leader in oncology therapeutics.

Frequently Asked Questions

What is the main focus of Kairos Pharma?

Kairos Pharma focuses on developing innovative cancer therapies, particularly targeting drug resistance.

Who will be speaking at the Maxim Healthcare Virtual Summit?

John S. Yu, M.D., CEO will be speaking with Jason McCarthy, Ph.D., during the summit.

When is the fireside chat scheduled?

The fireside chat is scheduled for October 17, 2024, at 1:00 PM ET.

What is ENV105?

ENV105 is Kairos Pharma's lead candidate targeting CD105, aiming to overcome drug resistance in cancer treatment.

How can I learn more about Kairos Pharma?

For further information, you can visit their official website at kairospharma.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

transcosmos & Metaverse Creators to Boost VRChat Content

Updated Category News Views 61

Charting the Course for Global VR Expansion transcosmos and Metaverse Creators are throwing down the gauntlet to the barriers between Japanese VR magic and the global market. They're teaming up to sling 3D content from creators in Japan straight to users worldwide via Geek Jack, a cross-border e-commerce bridge built for entertainment. You can't deny it—VRChat's allure...

Continue Reading
Azazie Pops Up in Phoenix: Bridal Gowns Galore

Updated Category News Views 45

A Wedding Dress Extravaganza in the Desert If you're prowling the bridal aisles looking for that dream dress, Azazie's got a showstopper planned for Phoenix on October 31. This ain't your typical online browsing! Azazie, known for flipping the bridal industry on its noggin, is swooping into Phoenix with a pop-up event that promises to shake up your wedding planning with a...

Continue Reading
Ramaco's Strategic Push into Critical Minerals Discussed

Updated Category News Views 48

An Industry Insider Speaks on Global Stage In the shuffle of corporate presentations and industry meet-ups, let's put Ramaco Resources and their executive vice president, Mike Woloschuk, into sharper focus. In Paris, he's set to address the plenary session of the International Energy Agency's Coal Industry Advisory Board. His talk titled 'Bringing Critical Minerals...

Continue Reading
Ecopetrol Sets Q3 2026 Results Release, Conference Call

Updated Category News Views 110

Big Day Incoming: Ecopetrol's Q3 Results Alright, folks, buckle up because Ecopetrol is about to drop its third-quarter numbers for 2026. On November 10th, after the bell, Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC) will lift the veil on its financial and operational performance. Make sure you got your calendars marked, and better yet, your browser's up to date. Nothing's...

Continue Reading
2026 Brand Value Surge: Nvidia Leads the Charge

Updated Category News Views 14

Nvidia Rockets Up the Brand Charts In a year where Interbrand's Best Global Brands list swelled past $3.87 trillion, Nvidia burst through the ranks with a jaw-dropping 71% surge in brand value, landing them at number six. You'd think they strapped a rocket to their brand—a sign of the times as AI is weaving itself deeper into the fabric of our lives. It's a classic case...

Continue Reading
Replay Sports Cards Nets STAR Award for Innovation

Updated Category News Views 53

A New Era for Franchise Onboarding Just when you think the sports card world couldn't get any more niche, along comes Replay Sports Cards thumping its chest with some serious innovation. This Charlotte-based franchise just snagged the Franchise Innovation Award from Franchise Update Media. Yep, they're the only ones getting tips of the hat for the Most Innovative...

Continue Reading
Local Expertise Key in Navigating Tahoe Real Estate

Updated Category News Views 68

Diving Into Tahoe's Unique Real Estate Scene If you think all real estate markets sing the same tune, take a stroll through South Lake Tahoe's offerings, and you'll find yourself singing a different song. Buying property in this neck of the woods requires more than a keen eye for granite countertops or a Zillow addiction. It demands a local guide—someone who knows the...

Continue Reading
Total Play's Q3 2026: Subscriber Surge, Debt Down

Updated Category News Views 66

Subscriber Growth Amidst Financial Hurdles Here’s the deal with Total Play's third-quarter results for 2026: they’ve got a mixed bag of numbers that’ll make any investor think twice. The headline is a hefty rise in subscribers—a net gain of 143,340 in the Residential segment thanks to their top-tier internet services. But don’t start cheering just...

Continue Reading
Spotlight on Disability Inclusivity: 10 Honorees Celebrated

Updated Category News Views 116

Celebrating Champions of Inclusivity April 17, 2026 was a red-letter day for hope and progress in Garden Grove. The Regional Center of Orange County (RCOC) hosted its 29th annual Spotlight Awards, tipping their hats to ten trailblazing individuals and organizations. In a society where the marginalized often get left out of the success parade, these folks are ahead of the...

Continue Reading
Photocure's Q3 2026: Revenue Plateau and CFO Shakeup

Updated Category News Views 50

The Bladder Cancer Scene: Steady as She Goes Sometimes, you look at numbers and find tranquility, like staring into still waters. That's the scene over at Photocure ASA with their latest Q3 results. Clocking in with revenues of NOK 134.2 million from their Hexvix®/Cysview® products, they're barely flinching from last year's NOK 134.1 million. Is it a victory or a...

Continue Reading

Top 5 Most Recently Viewed Articles

KPS Capital Partners Expands Portfolio with Ketjen Acquisition

Updated Category News Views 393

KPS Capital Partners Expands Portfolio with Ketjen Acquisition New Company Will Be a Global Leader in Advanced Catalysts and Additives for the Refining and Petrochemical Industries New York - KPS Capital Partners, LP ("KPS") is thrilled to announce its latest strategic move in the refining catalysts arena. Through a newly formed affiliate, KPS has signed a definitive...

Continue Reading
Skillful Craftsman Education Unveils Exciting New Strategies

Updated Category News Views 180

Skillful Craftsman Education Embraces Innovative Growth Strategies Skillful Craftsman Education Technology Limited (NASDAQ: EDTK) is stepping into a new phase of its journey. The company's latest business initiatives are aimed at propelling its growth amidst the rapidly changing technological landscape in education. Leadership Vision for Future Development Mr. Bin Fu, the...

Continue Reading
Planisware Reveals Share Count and Voting Rights Updates

Updated Category News Views 169

Overview of Planisware's Shares and Voting Rights In a continuous effort to maintain transparency and provide relevant information to shareholders, Planisware SA has released a comprehensive report detailing the total number of shares and voting rights that comprise its share capital. This information plays a crucial role for investors looking to understand the...

Continue Reading
Beach House Expands Addiction Treatment Capacity with New Beds

Updated Category News Views 56

Beach House Behavioral Health Announces Capacity Expansion Beach House Behavioral Health, Inc. is excited to share its continued growth in the field of addiction treatment services. The company has recently announced an expansion of its residential addiction treatment capacity with the introduction of 20 additional beds. This move demonstrates Beach House's commitment to...

Continue Reading
Medicus Pharma Welcomes Dr. Faisal Mehmud as CMO

Updated Category News Views 215

Medicus Pharma Welcomes a New Chief Medical Officer Medicus Pharma Ltd (NASDAQ: MDCX) is excited to announce a significant addition to its leadership team with the appointment of Dr. Faisal Mehmud as Chief Medical Officer. His extensive background in clinical development and medical affairs will greatly enhance the company’s capabilities in advancing innovative...

Continue Reading